Halden Zimmermann enjoys the challenge of business and bringing teams to the next level through inclusion and execution. Most of his time has been spent applying some simple tools to raise the bar with marketing, sales and operational business teams
By ANDREW POLLACK
Critics of biotechnology have long said that the current regulatory system is too lax.
Published: July 2, 2015 at 08:00PM
from NYT Business Day http://ift.tt/1GSqGVj
No comments:
Post a Comment